AI has swept through education — adopted by most schools and nearly all students — with tutors like Khanmigo posting measurable learning gains as regulators race to set guardrails.
Over half of 2026's layoffs cite AI, and young workers are hit hardest — but new research finds firms are cutting jobs regardless of whether the technology actually delivers returns.
Data centers could consume 1,050 TWh in 2026 — enough to rank as the world's fifth-largest 'country' for power. The limit on AI's growth is now the grid, not the silicon.
Samsung's June Galaxy Watch update adds AI features — Vitals, Heart Health Score, Daily Cardio Load and Fitness Index — that turn raw biometrics into daily, actionable guidance.
AI chatbots now run most routine support interactions, with 91% of mid-sized firms using them and the market headed for $15 billion in 2026 — reshaping a giant cost center.
AI-discovered drugs have flooded into clinical trials — 200-plus and counting — but none has yet won FDA approval, making 2026 the year the field has to prove it works.
Fed by sensors, drones and satellites, AI is now predicting yields, catching disease early and guiding irrigation — with precision-farming adopters seeing up to 20% higher yields.
Models like Mirai and Sybil can flag breast and lung cancer risk years early, and new tools and big-pharma deals are pushing AI imaging from the lab into the clinic.
From Foxconn's Nurabot to Diligent's Moxi, AI nursing robots are graduating from trials to real hospital floors — easing workloads as the global nurse shortage bites.
A Drexel University study finds users treat AI mental-health tools as supplements to human therapy — valuing the support while worrying about dependence and misinformation.